Furthermore, HαT is found to be two to three times more prevalent in patients with SM than in the general population [79], and additionally, patients with SM and concurrent HαT tend to present severe and more frequent symptoms of MC activation and anaphylaxis, in particular Hymenoptera venom anaphylaxis or IA [61,79,80]. This evidence concerns the gene TMPRSS11D and systemic mastocytosis.